HPV - ANOGENITAL HUMAN PAPILLOMA VIRUS INFECTION

Clinical trials for HPV - ANOGENITAL HUMAN PAPILLOMA VIRUS INFECTION explained in plain language.

Never miss a new study

Get alerted when new HPV - ANOGENITAL HUMAN PAPILLOMA VIRUS INFECTION trials appear

Sign up with your email to follow new studies for HPV - ANOGENITAL HUMAN PAPILLOMA VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 2 Not yet finished but already full! 1

Custom immune cells unleashed against multiple cancers in pioneering trial

Disease control Ongoing

This early-stage study is testing the safety of a new, personalized cell therapy for people with advanced solid tumors that have stopped responding to standard treatments. Doctors collect a patient's own immune cells, genetically modify them to better recognize and attack their s…

Matched conditions: HPV - ANOGENITAL HUMAN PAPILLOMA VIRUS INFECTION

Phase: PHASE1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control

Last updated Mar 16, 2026 15:26 UTC

HPV - ANOGENITAL HUMAN PAPILLOMA VIRUS INFECTION

Get alerted when new HPV - ANOGENITAL HUMAN PAPILLOMA VIRUS INFECTION trials appear

Custom immune cells unleashed against multiple cancers in pioneering trial